CHICAGO SAYS PFIZER AGREES TO DISCLOSE RISKS OF OPIOIDS

  • News
  • July 15, 2016
The city of Chicago says it has reached an agreement with Pfizer committing the drugmaker to disclosing the risks of addiction in its marketing of prescription opioid painkillers. Chicago is suing five pharmaceutical companies, alleging they have misrepresented the benefits of opioids while concealing serious health risks associated with the drugs. Pfizer Inc. is not named in the lawsuit. But Mayor Rahm Emanuel’s office said in its announcement that Pfizer has cooperated with the city’s investigation and the legal action. The agreement with Pfizer also bars it from supporting organization or individual who make inaccurate claims about the risks and benefits of opioids.

Related Posts

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Prescription Drug Diversion Crisis Deepens Across India: Massive Seizures of Pregabalin, Tramadol, Codeine Syrup and Psychotropic Capsules Expose Regulatory Failure

Prescription Drug Diversion Crisis Deepens Across India: Massive Seizures of Pregabalin, Tramadol, Codeine Syrup and Psychotropic Capsules Expose Regulatory Failure

US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

Six Women Develop Serious Complications After C-Section

Six Women Develop Serious Complications After C-Section

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Indian Pharma Majors Plan to Invest in US

Indian Pharma Majors Plan to Invest in US